Latest immunotherapy news
Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Circulating Tumor DNA Linked to Poor Prognosis in HER2-Positive Early Breast Cancer
posted January 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Cancer Drug Shortages Persist at All Cancer Centers 
Relapse Rare After Appendiceal Adenocarcinoma Resection Related Articles
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Monthly Specialist Briefings
Stay Connected
